TabletMifepristone + Misoprostol Kit
Mifepristone + Misoprostol
WHO-recommended two-drug MTP regimen combining mifepristone (antiprogestogen) with misoprostol (prostaglandin) for safe, effective non-surgical pregnancy termination up to 9 weeks gestation with efficacy exceeding 95%. Prescription-only kit manufactured by Cipla and Sun Pharma and exported to global reproductive health programs and regulated pharmacy channels.
Strengths
200mg + 200mcg
Packing
1 kit/box
Origin
India (WHO-GMP)
MOQ
100 units
Export Price
On Request
Availability
In Stock
Product Specifications
Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.
Related Products
GelTestosterone Gel 1%
Testosterone
Transdermal testosterone replacement therapy delivering consistent physiological testosterone levels through daily skin application, designed for men with primary or secondary hypogonadism requiring a convenient and non-invasive hormone replacement option. Packaged in pre-measured 5g sachets for precise 50mg dosing and exported from India in 30-sachet boxes to international men's health and hormone therapy markets.
InjectionTestosterone Enanthate 250mg
Testosterone Enanthate
Long-acting testosterone ester in oil providing sustained serum testosterone levels lasting 2-4 weeks per injection, making it the most widely used injectable TRT formulation for male hypogonadism, delayed puberty, and gender-affirming hormone therapy. Manufactured to GMP standards by Zydus Cadila and exported in single-dose ampoules for urology, endocrinology, and men's health clinics worldwide.
TabletAnastrozole 1mg
Anastrozole
Potent non-steroidal aromatase inhibitor that selectively blocks estrogen biosynthesis by >99% in postmenopausal women, making it the first-line adjuvant therapy for hormone receptor-positive breast cancer and a key component of testosterone replacement protocols to control estrogen conversion. Manufactured by leading Indian oncology companies and exported globally as a cost-effective alternative to Arimidex for both oncology and men's health indications.
Need bulk pricing for Mifepristone + Misoprostol Kit?
Send us your quantity requirements and destination country for a custom quotation.
Get Bulk Quote